Anti-HIV agents. Is PF-232798 a possible successor to maraviroc?
D053961:Azabicyclo Compounds; D018791:CD4 Lymphocyte Count; D003510:Cyclohexanes / Q000627:therapeutic use*; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D000077592:Maraviroc; D010880:Piperidines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D014326:Tropanes; D019562:Viral Load
D053961:Azabicyclo Compounds; D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D007093:Imidazoles; D010880:Piperidines; D014230:Triazoles; D014326:Tropanes; C530956:PF 232798; D000077592:Maraviroc